Regulatory T-cell Therapy (Orca Biosystems)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameRegulatory T-cell Therapy (Orca Biosystems)
Drug Alias NamePurified regulatory T-cell Therapy
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsMyeloproliferative DisordersMyelodysplastic SyndromesHematologic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrca Biosystems Inc
China Registration ClassN/A

Develop Information

Active CompaniesStanford UniversityOrca Biosystems Inc
Inactive CompaniesN/A
Active IndicationsMyeloproliferative DisordersMyelodysplastic SyndromesHematologic Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A